Resources

Veranex’s Health Economic Model Demonstrates the Potential Cost-Savings from the French Payer Perspective of Using the EXENT® GAM Assay* for Monitoring Patients with Multiple Myeloma

The investigational model considered the use of the EXENT® GAM Assay from the Binding Site, part of Thermo Fisher Scientific. This is a mass spectrometry method that may replace current immunofixation testing and may inform the timing of bone...

Read More

1 min read

EU Batteries Regulation

Speaker Rossella Fontana Date May 14th, 2025, Online Duration 3 hours | 9:00 – 12:00 AM US Eastern Daylight Time, 3:00 – 6:00 PM Central Europe...

Read More

1 min read

Introduction to FDA Regulatory Process for EU Companies

Speaker Paige Sutton-Smith Date May 20th, 2025, Online Duration 3 hours | 9:00 – 12:00 AM US Eastern Daylight Time, 3:00 – 6:00 PM Central Europe...

Read More

Clinical Trials Strategic Summit 2023

May 10-11, 2023 Boston, MA

Read More

Medical Alley 2023 Annual Dinner

May 11, 2023 4:30 PM CDT Minneapolis, MN

Read More

Never Miss an Opportunity

Nothing is more expensive than a missed opportunity. With the power and expertise of Veranex, we can propel your product journey towards the correct...

Read More

1 min read

The Productization of Translational Science

April 26, 2023 3pm BST (UK) / 4pm CEST (EU-Central) / 10am EDT / 9am CDT

Read More

PCR Innovators Day

May 15, 2023 Paris, France

Read More

1 min read

How Policy is Driving Digital Health in Germany

Several recent national-level policy changes highlight an accelerating digital transformation of healthcare in Germany, building on the Digital...

Read More